4. Strategies for Assessing, Monitoring, and Addressing Special Considerations with Controlled Substances

  1. Marie Annette Brown PhD, ARNP, FNP-BC, FAAN and
  2. Louise Kaplan PhD, ARNP, FNP-BC, FAANP
  1. Pamela Stitzlein Davies

Published Online: 15 MAY 2013

DOI: 10.1002/9781118696965.ch4

The Advanced Practice Registered Nurse as a Prescriber

The Advanced Practice Registered Nurse as a Prescriber

How to Cite

Brown, M. A. and Kaplan, L. (2012) Strategies for Assessing, Monitoring, and Addressing Special Considerations with Controlled Substances, in The Advanced Practice Registered Nurse as a Prescriber, John Wiley & Sons, Ltd., West Sussex, UK. doi: 10.1002/9781118696965.ch4

Publication History

  1. Published Online: 15 MAY 2013
  2. Published Print: 6 FEB 2012

ISBN Information

Print ISBN: 9780813805245

Online ISBN: 9781118696965

SEARCH

Keywords:

  • Controlled substances (CSs);
  • Drug Abuse Warning Network (DAWN);
  • Mood disorders;
  • Opioid risk tool (ORT);
  • Urine drug testing (UDT);
  • Veterans administration (VA)

Summary

This chapter contains sections titled:

  • CSS and Related Definitions

  • The “Decade of Pain Control” Versus the “War on Drugs”

  • Recommended Practices for Prescribers of Controlled Substances

  • Approaches to Assessment and Management

  • Prescribing Controlled Substances

  • Summary